Vivanta Industries Ltd
VIVANTAVivanta Industries Ltd
VIVANTA
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 231.58 | 2.67 | 0.85% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.92 | 6.65 | 0.51% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Vivanta Industries is engaged in trading of pharmaceutical products.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.01 | 0.54 | 1.91 | 24.82 | 37.31 | 19.64 | ||||||
Raw Materials | 0.37 | 0.00 | 1.15 | 22.57 | 36.40 | 18.70 | ||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Employee Cost | 0.33 | 0.29 | 0.16 | 0.42 | ||||||||
| Selling & Administrative Expenses | 0.14 | 0.07 | 0.10 | 0.26 | ||||||||
| Operating & Other expenses | 0.04 | 0.07 | 0.02 | -1.30 | ||||||||
EBITDA | -0.36 | 0.03 | 0.33 | 1.97 | 1.53 | 0.94 | ||||||
| Depreciation/Amortization | 0.04 | 0.19 | 0.18 | 0.16 | 0.19 | 0.33 | ||||||
| PBIT | -0.40 | -0.16 | 0.15 | 1.81 | 1.34 | 0.61 | ||||||
| Interest & Other Items | 0.00 | 0.01 | 0.01 | 0.01 | 0.03 | 0.05 | ||||||
| PBT | -0.40 | -0.17 | 0.14 | 1.80 | 1.31 | 0.56 | ||||||
| Taxes & Other Items | -0.01 | 0.01 | 0.00 | 0.49 | 0.37 | 0.37 | ||||||
| Net Income | -0.39 | -0.18 | 0.14 | 1.31 | 0.94 | 0.19 | ||||||
| EPS | -0.03 | -0.01 | 0.01 | 0.09 | 0.08 | 0.02 | ||||||
| DPS | — | 0.00 | 0.00 | 0.02 | 0.03 | 0.00 | ||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.26 | 0.40 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Vivanta Industries Ltd | 46.81 | 2.67 | 0.85% |
| Sun Pharmaceutical Industries Ltd | 45.12 | 6.44 | 0.75% |
| Cipla Ltd | 28.85 | 4.44 | 0.88% |
| Torrent Pharmaceuticals Ltd | 69.10 | 16.69 | 0.83% |
Price Comparison
Compare VIVANTA with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 5, 2023
Dividend/Share
₹0.03
Ex DateEx Date
Sep 5, 2023
Vivanta Industries announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 7 January 2025.Powered by Capital Market - Live
Vivanta Industries announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 7 January 2025.Powered by Capital Market - Live
Vivanta Industries will hold a meeting of the Board of Directors of the Company on 9 December 2024Powered by Capital Market - Live
Vivanta Industries has revised the meeting of the Board of Directors which was scheduled to be held on 15 November 2024. The meeting will now be held on 22 November 2024.Powered by Capital Market - Live
Vivanta Industries will hold a meeting of the Board of Directors of the Company on 15 November 2024Powered by Capital Market - Live
Net profit of Vivanta Industries declined 95.59% to Rs 0.03 crore in the quarter ended September 2024 as against Rs 0.68 crore during the previous quarter ended September 2023. Sales declined 79.22% to Rs 1.86 crore in the quarter ended September 2024 as against Rs 8.95 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1.868.95 -79 OPM %5.918.04 - PBDT0.140.72 -81 PBT0.030.68 -96 NP0.030.68 -96 Powered by Capital Market - Live
Vivanta Industries will hold a meeting of the Board of Directors of the Company on 24 October 2024.Powered by Capital Market - Live
Vivanta Industries has received the contract valued at Rs 26 crore for procurement of medicines, machines & technology from P. G. Madagascar. Powered by Capital Market - Live
Vivanta Industries announced that the 11th Annual General Meeting (AGM) of the company will be held on 22 August 2024.Powered by Capital Market - Live
Vivanta Industries consolidated net profit declines 21.21% in the June 2024 quarter
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 1.04%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant